Literature DB >> 26674929

Human Papillomavirus in Oral Leukoplakia, Verrucous Carcinoma, Squamous Cell Carcinoma, and Normal Mucous Membrane.

Nasrollah Saghravanian1, Narges Ghazi2, Zahra Meshkat3, Nooshin Mohtasham1.   

Abstract

OBJECTIVES: Squamous cell carcinoma (SCC) is the most common oral malignancy, and verrucous carcinoma (VC) is a less invasive type of SCC. Leukoplakia (LP) is the most frequent premalignant lesion in the oral cavity. The human papillomavirus (HPV) has been recognized as one of the etiologic factors of these conditions. The association of anogenital and cervical cancers with HPV particularly its high-risk subtypes (HPV HR) has been demonstrated. The purpose of our study was to investigate the hypothetical association between HPV and the mentioned oral cavity lesions.
METHODS: One hundred and seventy-three samples (114 SCCs, 21 VCs, 20 LPs) and 18 normal mucosa samples (as a control group) were retrieved from the Department of Oral and Maxillofacial Pathology of Mashhad Dental School, Iran. The association of HPV genotypes in LP, VC, and SCC was compared to normal oral mucosa using the polymerase chain reaction.
RESULTS: The results showed the absence of HPV in normal mucosa and LP lesions. In three samples of VC (14.3%), we observed the presence of HPV HR (types 16 and 18). All VCs were present in the mandibular ridge of females aged over 65 years old. No statistically significant correlation between HPV and VC was observed (p=0.230). Additionally, 15 (13.1%) SCCs showed HPV positivity, but this was not significant (p=0.830). The prevalence of SCC was higher on the tongue with the dominant presence of less carcinogenic species of HPV (types 6 and 11). A statistically significant association was not observed between HPV and SCC or VC in the oral cavity.
CONCLUSION: More studies are necessary to better understand the relationship between HPV and malignant/premalignant oral cavity lesions.

Entities:  

Keywords:  Carcinoma, Squamous Cell; Carcinoma, Verrucous; Leukoplakia, Oral

Year:  2015        PMID: 26674929      PMCID: PMC4678447          DOI: 10.5001/omj.2015.89

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  26 in total

1.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

Review 2.  HPV-11- and HPV-16-associated oral verrucous carcinoma.

Authors:  J Lübbe; A Kormann; V Adams; S Hassam; K W Grätz; R G Panizzon; G Burg
Journal:  Dermatology       Date:  1996       Impact factor: 5.366

3.  Immunophenotyping of HPV Types 16 and 18 among Sudanese Patients with Oral Lesions.

Authors:  Ibrahim A M Ginawi; Ebtihag A Mahgoub; Hussain G Ahmed
Journal:  Oman Med J       Date:  2012-05

4.  Analysis of oral papillomas, leukoplakias, and invasive carcinomas for human papillomavirus type related DNA.

Authors:  T Löning; H Ikenberg; J Becker; L Gissmann; I Hoepfer; H zur Hausen
Journal:  J Invest Dermatol       Date:  1985-05       Impact factor: 8.551

5.  Human herpes simplex-1 and papillomavirus type 16 homologous DNA sequences in normal, potentially malignant and malignant oral mucosa.

Authors:  M Cox; N Maitland; C Scully
Journal:  Eur J Cancer B Oral Oncol       Date:  1993-07

6.  The use of nested polymerase chain reaction and restriction fragment length polymorphism for the detection and typing of mucosal human papillomaviruses in samples containing low copy numbers of viral DNA.

Authors:  Patti Kay; Kathleen Meehan; Anna-Lise Williamson
Journal:  J Virol Methods       Date:  2002-08       Impact factor: 2.014

7.  Human papillomavirus infection in oral verrucous carcinoma: genotyping analysis and inverse correlation with p53 expression.

Authors:  Shuichi Fujita; Masachika Senba; Atsushi Kumatori; Tomayoshi Hayashi; Tohru Ikeda; Kan Toriyama
Journal:  Pathobiology       Date:  2008-06-26       Impact factor: 4.342

8.  Human papillomavirus in oral lesions.

Authors:  Joaquín V González; Rafael A Gutiérrez; Alicia Keszler; Maria del Carmen Colacino; Lidia V Alonio; Angelica R Teyssie; Maria Alejandra Picconi
Journal:  Medicina (B Aires)       Date:  2007       Impact factor: 0.653

9.  Progressive increase of human papillomavirus carriage rates in potentially malignant and malignant oral disorders with increasing malignant potential.

Authors:  K Szarka; I Tar; E Fehér; T Gáll; A Kis; E D Tóth; R Boda; I Márton; L Gergely
Journal:  Oral Microbiol Immunol       Date:  2009-08

Review 10.  HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007).

Authors:  N Termine; V Panzarella; S Falaschini; A Russo; D Matranga; L Lo Muzio; G Campisi
Journal:  Ann Oncol       Date:  2008-06-16       Impact factor: 32.976

View more
  3 in total

1.  Molecular and Immunohistochemical Cognizance of HPV16 in Oral Leukoplakia, Oral Squamous Cell Carcinoma and Oropharyngeal Squamous Cell Carcinoma.

Authors:  N Sivakumar; Anjali Narwal; Mala Kamboj; Anju Devi; Sanjay Kumar; Rashmi Bhardwaj
Journal:  Head Neck Pathol       Date:  2021-02-28

2.  Human papillomavirus and leukoplakia of the oral cavity: a systematic review.

Authors:  Dominik Radzki; Aida Kusiak; Iwona Ordyniec-Kwaśnica; Arleta Bondarczuk
Journal:  Postepy Dermatol Alergol       Date:  2021-09-20       Impact factor: 1.664

3.  Human Papillomavirus 16 and 18 Infection in Oral Cancer in Thailand: A Multicenter Study.

Authors:  Nicha Komolmalai; Surawut Pongsiriwet; Nirush Lertprasertsuke; Suree Lekwanavijit; Sompid Kintarak; Ekarat Phattarataratip; Ajiravudh Subarnbhesaj; Kittipong Dhanuthai; Risa Chaisuparat; Anak Iamaroon
Journal:  Asian Pac J Cancer Prev       Date:  2020-11-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.